Brief Communication Yonsei Med J 2016 Sep;57(5):1276-1281 http://dx.doi.org/10.3349/ymj.2016.57.5.1276
pISSN: 0513-5796 · eISSN: 1976-2437
Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy Dai Hoon Han1,2, Dong Jin Joo1,2,3, Myoung Soo Kim1,3, Gi Hong Choi1,2,3, Jin Sub Choi1,2,3, Young Nyun Park2,4, Jinsil Seong2,5, Kwang-Hyub Han2,6, and Soon Il Kim1,3 Department of Surgery, 2Liver Cancer Special Clinic, 3Research Institute for Transplantation, Departments of 4Pathology, Radiological Oncology, and 6Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
1 5
Locally advanced hepatocellular carcinoma (HCC) with portal vein thrombosis carries a 1-year survival rate
pISSN: 0513-5796 · eISSN: 1976-2437
Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy Dai Hoon Han1,2, Dong Jin Joo1,2,3, Myoung Soo Kim1,3, Gi Hong Choi1,2,3, Jin Sub Choi1,2,3, Young Nyun Park2,4, Jinsil Seong2,5, Kwang-Hyub Han2,6, and Soon Il Kim1,3 Department of Surgery, 2Liver Cancer Special Clinic, 3Research Institute for Transplantation, Departments of 4Pathology, Radiological Oncology, and 6Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
1 5
Locally advanced hepatocellular carcinoma (HCC) with portal vein thrombosis carries a 1-year survival rate
